{
    "organizations": [],
    "uuid": "70ad39de08c1ef0dbc3cf02a5c0843c1b49f8986",
    "author": "",
    "url": "https://www.reuters.com/article/brief-theravance-biopharma-q4-revenue-45/brief-theravance-biopharma-q4-revenue-4-5-million-idUSASB0C7TD",
    "ord_in_thread": 0,
    "title": "BRIEF-Theravance Biopharma Q4 Revenue $4.5 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Theravance Biopharma Inc:\n* THERAVANCE BIOPHARMA, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* Q4 REVENUE $4.5 MILLION * ‍ANTICIPATES FULL YEAR 2018 OPERATING LOSS, EXCLUDING SHARE-BASED COMPENSATION, WILL BE IN RANGE OF $180.0 TO $200.0 MILLION​\n* QTRLY ‍LOSS PER SHARE $1.64​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T00:09:00.000+02:00",
    "crawled": "2018-02-28T00:22:15.008+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "theravance",
        "biopharma",
        "inc",
        "theravance",
        "biopharma",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q4",
        "revenue",
        "million",
        "full",
        "year",
        "operating",
        "loss",
        "excluding",
        "compensation",
        "range",
        "qtrly",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}